about
Simeprevir and Sofosbuvir Combination Treatment in a Patient with HCV Cirrhosis and HbS Beta 0-Thalassemia: Efficacy and Safety despite Baseline Hyperbilirubinemia.Associations Between Lifestyle Characteristics and the Presence of Nonalcoholic Fatty Liver Disease: A Case-Control Study.Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece.Sarcoidosis in untreated chronic hepatitis C virus infection.Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load.Hepatitis C infection in patients with hereditary bleeding disorders: epidemiology, natural history, and management.A "healthy diet-optimal sleep" lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease.Multifocal splenic abscesses in immunocompetent adult due to cat-scratch disease.Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues.HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?Milky nailsPrimary sclerosing cholangitis lesions in a patient with Crohn's disease and HCV infectionNitric oxide, ammonia, and CRP levels in cirrhotic patients with hepatic encephalopathy: is there a connection?Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trialPersistence and adherence to nucleos(t)ide analogues in chronic hepatitis B: a multicenter cohort studyEvaluation of the effectiveness of eight screening tools in detecting risk of malnutrition in cirrhotic patients: the KIRRHOS studyValidation of cutoffs for skeletal muscle mass index based on computed tomography analysis against dual energy X-ray absorptiometry in patients with cirrhosis: the KIRRHOS studyLiver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography
P50
Q36690603-F81E1CD7-4024-4540-81C2-0C39C83F6BA6Q39169093-B996B5E8-1E2F-4E24-B82D-5DE6983AD7CFQ40527347-8566A1F1-7016-49E0-9012-3A497C50D4F2Q42989420-616694AC-D9AA-4081-8999-A2C616EA0EC1Q43458944-3CD6F71B-EF4E-4C16-9D93-5340BCB2960AQ45370707-0025A3F3-65B1-44F6-A112-7E77DA2B04C5Q47553814-1F44CA7A-CD85-401F-A823-12A75000D956Q47769655-A80A8D2E-B82E-475D-B1A4-5BD087CB9A97Q49423692-E71F1467-DCCF-409D-A189-02779E040007Q54222473-3C49CB60-F8E6-413C-8B99-AC6F7641D55CQ59350326-A44D5C6A-54FA-4103-AE08-E4ADF9F956D8Q79993778-421427F1-0FA9-46DC-A184-DC1C45098E8FQ80529369-EE4AE108-E796-49C1-A3EB-B9C0EE323469Q84285405-20281551-EB0B-43E1-92CF-1B3A4258CCD6Q89276405-1BF41372-6249-4AA4-8634-C4B38688BD66Q91118768-727D6A58-CD41-4CF7-8506-3EFB50E372E0Q91310603-A301DB25-7C0E-4126-BB1E-76A343A7B67CQ92357852-B384F70D-1555-4948-AFEC-BE8A9CDDE380Q93046532-F99E33AD-5456-4CAE-8599-3CF1CE77F9C5
P50
description
Greek medical researcher
@en
investigador
@es
name
Nikolaos Papadopoulos
@en
Papadopoulos N
@nl
type
label
Nikolaos Papadopoulos
@en
Papadopoulos N
@nl
altLabel
Papadopoulos N
@en
prefLabel
Nikolaos Papadopoulos
@en
Papadopoulos N
@nl
P106
P31
P496
0000-0002-8702-1685